Prior coronavirus outbreaks, like MERS and SARS, can give us some insight into some of the more natural treatments that we may consider pursuing.
While there are many clinical trials awaiting results, there are some things we know that may help us along the way. These are not recommendations so much as they are considerations based on what we know.
Sambucus Formosana Nakai
This is a type of elderberry that has been shown to have positive effects against past coronaviruses (not COVID-19, specifically).
While it is not like the elderberry syrup you might find in the grocery store, the caffeic-acid richness found in it may have a positive effective (which may also relate to foods like turmeric, basil, thyme, oregano, sage, cabbage, apples, strawberries, cauliflower, radishes, mushrooms, kale, pears, and olive oil).
Echinacea is known as both antiviral and preventive. In addition, it has been shown as effective against the avian virus in animal studies3.
In the past, echinacea was thought to be a concern for autoimmune disease. That said, this concern has become less and less relevant.
We know that it works through immune modulation and not simple immune stimulation. It is also known to be safe and effective for long-term use4.
In living animal and test-tube studies, this has been shown to kill other coronaviruses. This study, in particular, suggested that it has the potential to diminish disease progression in chickens and could be used to the control of coronaviruses5.
This compound has been shown to make influenza viruses less able to cause pulmonary damage in the body6. It also has antiviral and immunoregulatory properties7.
The effects of glycans are both simple and complex and can play a profound role in metabolic, structural, and physical roles in biological systems. In knowing this, we can learn more about their evolutionary role and what they can tell us about biological complexity8.
By tradition, viral glycan-binding proteins are called hemagglutinins. The best known of these is probably influenza hemagglutinin (the “H” in “H1N1” or Swine Flu).
The evolution of the avian influenza viruses towards infecting humans involves selection for a change in binding specificity, which can be replicated experimentally.
After taking antibiotics, more at risk for viral infections entering the body through the GI tract. That said, saccharomyces boulardii, has been shown to reduce the risk of translocation of these viral illnesses9.
IV Vitamin C
China is now performing a clinical trial of 24 grams, per day, of vitamin C delivered intravenously. This is a clinical trial registered with the United States NIH10.
Vitamin C delivered through an IV has been used for decades to treat existing infectious diseases. It has both been used by itself and in coordination with other treatments for septicemia and has been shown to improve overall survival11.
It has also lowered the risk of death from other infectious diseases including tetanus12.
Lastly, it can also be used as a standalone therapy to lower the risk of developing viral infections.
Using IV Vitamin C
As a preventive measure, IV vitamin C can be taken in doses at least 20 grams (20,000) mg up to once per week for those at risk.
Please note that those with a genetic condition called G6PD deficiency may be at risk for hemolysis when receiving extremely high doses of IV vitamin C.